Antonio Román

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

Marc Humbert, David Pittrow, Gérald Simonneau et al. · Respiratory Medicine · 2020 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center

Alfredo Castillo, Eduardo L. Callejas-Moraga, Gabriela García et al. · Arthritis Research & Therapy · 2017 · 28 citations · Full text

Medicine, Cardiology, Clinical Cardiology +15

Impairment of pulmonary vascular reserve and right ventricular systolic reserve in pulmonary arterial hypertension

Enric Domingo, Juan C. Grignola, Río Aguilar et al. · BMC Pulmonary Medicine · 2014 · 27 citations · Full text

Medicine, Cardiology, Clinical Cardiology +13

In Vivo Assessment of Pulmonary Arterial Wall Fibrosis by Intravascular Optical Coherence Tomography in Pulmonary Arterial Hypertension: A New Prognostic Marker of Adverse Clinical Follow-Up§

Enric Domingo, Juan C. Grignola, Río Aguilar et al. · The Open Respiratory Medicine Journal · 2013 · 27 citations · Full text

Medicine, Cardiology, Pathology +13